Congenital heart disease
Pro Research Analysisby 
Searched over 200M research papers
Congenital Heart Disease: Prevalence and Global Burden
Congenital heart disease (CHD) is the most common birth defect worldwide, affecting about 1% of live births across all countries and populations, with little change in incidence over the past decades Hoffman1990Zimmerman2020Van Der Bom2010+1 MORE. Despite this stable birth prevalence, the number of people living with CHD has increased due to improved survival rates, resulting in more adults than children now living with the condition Zimmerman2020Van Der Bom2010Bouma2017. Globally, CHD caused over 260,000 deaths in 2017, with most deaths occurring in infants and in countries with lower socioeconomic status . While mortality rates have declined, the overall burden of CHD remains high, and many survivors face long-term complications such as heart failure and arrhythmias Zimmerman2020Van Der Bom2010Bouma2017.
Genetic and Molecular Basis of Congenital Heart Disease
Research has shown that CHD has a strong genetic component, with about 400 genes implicated in its development Williams2019Nees2019Pierpont2018+2 MORE. These genes include those involved in transcription regulation, cell signaling, chromatin modification, and cilia function, all of which are crucial for normal heart development Williams2019Pierpont2018Zaidi2017+1 MORE. Genetic causes of CHD are diverse and include chromosomal abnormalities, copy number variants, and single-gene mutations, which can be inherited or occur de novo Nees2019Pierpont2018Zaidi2017. Chromosomal abnormalities or aneuploidies are found in about 8-12% of CHD cases, copy number variations in 3-25%, and single-gene defects in 3-5% . The likelihood of identifying a genetic cause is higher in patients with CHD associated with other anomalies or syndromes Nees2019Pierpont2018.
Advances in Diagnosis and Research
Recent advances in genomic technologies, such as single-nucleus RNA sequencing and molecular testing, have improved the understanding and diagnosis of CHD Pierpont2018Hill2022. These techniques have revealed disease-specific changes in heart cells and immune profiles, providing new insights into disease mechanisms and potential personalized treatments . Animal models and human stem cell studies have also contributed to understanding the genetic and developmental pathways involved in CHD Pierpont2018Bruneau2008.
Inheritance and Family Risk
There is a genetic risk for CHD in families, with up to 10% of children born to parents with CHD also being affected . As more patients with CHD survive into adulthood and have children, the number of familial cases is expected to rise slowly .
Clinical Management and Long-Term Outcomes
Improvements in surgical and medical care have dramatically increased survival rates for CHD patients, but many still experience late complications such as arrhythmias, heart failure, and infections Van Der Bom2010Bouma2017. Ongoing care by specialized, multidisciplinary teams is essential for managing these complications and improving quality of life Van Der Bom2010Bouma2017. There is also a growing focus on addressing secondary issues like exercise, pregnancy, and social challenges for CHD patients .
Conclusion
Congenital heart disease remains a significant global health issue, with a stable incidence but increasing prevalence due to better survival. Genetic factors play a major role in its development, and advances in genomics are enhancing diagnosis and understanding. Despite progress, CHD continues to cause substantial morbidity and mortality, highlighting the need for improved care, research, and policy efforts to address global disparities and long-term patient needs Williams2019Nees2019Hoffman1990+7 MORE.
Sources and full results
Most relevant research papers on this topic